- Home
- MRUS vs PENN Comparison
MRUS vs PENN Comparison
Compare MRUS & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- PENN
- Stock Information
- Founded
- MRUS 2003
- PENN 1972
- Country
- MRUS Netherlands
- PENN United States
- Employees
- MRUS N/A
- PENN N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- PENN Hotels/Resorts
- Sector
- MRUS Health Care
- PENN Consumer Discretionary
- Exchange
- MRUS Nasdaq
- PENN Nasdaq
- Market Cap
- MRUS 3.6B
- PENN 3.1B
- IPO Year
- MRUS 2016
- PENN 1994
- Fundamental
- Price
- MRUS $46.58
- PENN $20.78
- Analyst Decision
- MRUS Strong Buy
- PENN Buy
- Analyst Count
- MRUS 10
- PENN 18
- Target Price
- MRUS $86.70
- PENN $23.23
- AVG Volume (30 Days)
- MRUS 376.4K
- PENN 2.8M
- Earning Date
- MRUS 10-31-2024
- PENN 11-07-2024
- Dividend Yield
- MRUS N/A
- PENN N/A
- EPS Growth
- MRUS N/A
- PENN N/A
- EPS
- MRUS N/A
- PENN N/A
- Revenue
- MRUS $35,932,000.00
- PENN $6,304,500,000.00
- Revenue This Year
- MRUS N/A
- PENN $6.63
- Revenue Next Year
- MRUS $52.49
- PENN $5.63
- P/E Ratio
- MRUS N/A
- PENN N/A
- Revenue Growth
- MRUS N/A
- PENN N/A
- 52 Week Low
- MRUS $22.26
- PENN $13.50
- 52 Week High
- MRUS $61.61
- PENN $27.21
- Technical
- Relative Strength Index (RSI)
- MRUS 32.37
- PENN 58.29
- Support Level
- MRUS $48.42
- PENN $20.05
- Resistance Level
- MRUS $53.49
- PENN $21.75
- Average True Range (ATR)
- MRUS 2.17
- PENN 0.89
- MACD
- MRUS -0.54
- PENN 0.13
- Stochastic Oscillator
- MRUS 5.73
- PENN 71.97
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 89% of total sales in 2023; 11% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.